DE69721493D1 - Transduktion von menschlichen hämatopoiestischen stammzellen - Google Patents

Transduktion von menschlichen hämatopoiestischen stammzellen

Info

Publication number
DE69721493D1
DE69721493D1 DE69721493T DE69721493T DE69721493D1 DE 69721493 D1 DE69721493 D1 DE 69721493D1 DE 69721493 T DE69721493 T DE 69721493T DE 69721493 T DE69721493 T DE 69721493T DE 69721493 D1 DE69721493 D1 DE 69721493D1
Authority
DE
Germany
Prior art keywords
human
stem cells
hemopopiestic
transduction
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69721493T
Other languages
English (en)
Inventor
T Jordan
Steve Hardy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cell Genesys Inc
Original Assignee
Cell Genesys Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cell Genesys Inc filed Critical Cell Genesys Inc
Application granted granted Critical
Publication of DE69721493D1 publication Critical patent/DE69721493D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69721493T 1996-02-05 1997-02-05 Transduktion von menschlichen hämatopoiestischen stammzellen Expired - Lifetime DE69721493D1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US1117296P 1996-02-05 1996-02-05
US1121996P 1996-02-06 1996-02-06
US2168396P 1996-07-12 1996-07-12
PCT/US1997/001476 WO1997028269A1 (en) 1996-02-05 1997-02-05 Transduced human hematopoietic stem cells

Publications (1)

Publication Number Publication Date
DE69721493D1 true DE69721493D1 (de) 2003-06-05

Family

ID=27359380

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69721493T Expired - Lifetime DE69721493D1 (de) 1996-02-05 1997-02-05 Transduktion von menschlichen hämatopoiestischen stammzellen

Country Status (7)

Country Link
US (1) US20020061293A1 (de)
EP (1) EP0879294B1 (de)
JP (1) JP2000505284A (de)
AT (1) ATE239074T1 (de)
AU (1) AU717974B2 (de)
DE (1) DE69721493D1 (de)
WO (1) WO1997028269A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9818432D0 (en) 1998-08-24 1998-10-21 Bioline Limited Thermostable DNA Polymerase
JP4833443B2 (ja) * 2001-06-27 2011-12-07 旭化成株式会社 造血幹細胞の採取方法
EP3356520B1 (de) 2015-10-02 2022-03-23 The U.S.A. as represented by the Secretary, Department of Health and Human Services Lentivirales protein übertragungssystem zum rna-vermittelten genomeditieren

Also Published As

Publication number Publication date
US20020061293A1 (en) 2002-05-23
EP0879294B1 (de) 2003-05-02
JP2000505284A (ja) 2000-05-09
EP0879294A1 (de) 1998-11-25
AU717974B2 (en) 2000-04-06
WO1997028269A1 (en) 1997-08-07
AU1847597A (en) 1997-08-22
ATE239074T1 (de) 2003-05-15

Similar Documents

Publication Publication Date Title
ATE187491T1 (de) Isolierung, selektion und vermehrung von tierischen transgen-stammzellen
ES2058083T3 (es) Anticuerpos monoclonales contra el factor humano de la necrosis tumoral (tnf) y su empleo.
ATE238764T1 (de) Hautpflegemittel und verfahren zur verbesserung des hauterscheinungsbildes
DE69733247D1 (de) Humanisiertes grünes-fluoreszenzprotein und methoden
ATE238020T1 (de) Hautpflegezusammensetzungen und methode für die verbesserung des hautaussehens
DE69413039D1 (de) Prostaglandin rezeptor fp und kodierende dns
ATE402698T1 (de) Verwendung von ppar-gamma aktivatoren zur behandlung von hautkrankheiten
DK0670735T3 (da) Perifisering af hæmotopoietiske stamceller.
NO960767L (no) Protocadherinproteiner og deres anvendelse
DE69426033D1 (de) Für die alpha-1e untereinheit des menschlichen kalziumkanals kodierende dna
ID23374A (id) Halogenopirimidin
ATE236932T1 (de) Dna kodierend für prostaglandin rezeptor ip
DE69630955T2 (de) Immortalisierung bzw. desimmortalisierung von zellen
DK0938308T3 (da) Antiparasitiske midler
AU2003226127A1 (en) Antibody libraries
DE69405230D1 (de) Prostaglandinrezeptor ep1 kodierende dna
ATE239074T1 (de) Transduktion von menschlichen hämatopoiestischen stammzellen
ATE172471T1 (de) Prostaglandin rezeptor ep3 und kodierende dns
ATE254659T1 (de) Mikroorganismen, ihre herstellung und verwendung
PT870015E (pt) Novas xilanases os genes que as codificam e as suas utilizacoes
FI960839A0 (fi) Uusia tripeptidejä, jotka ovat käyttökelpoisia immuuni- ja CNS-terapiassa
ES2152959T3 (es) Utilizacion en perfumeria de isomeros opticamente activos del (e)-3,3-dimetil-5-(2,2,3-trimetil-3-ciclopenten-1-il)-4-penten-2-ol.
IT1251961B (it) Peptidi che rappresentano permutazioni della sequenza del mastoparano
DE69827808D1 (de) Protease-ähnliches protein
DE69418050D1 (de) Antivirale analoge von difluorostaton

Legal Events

Date Code Title Description
8332 No legal effect for de